7-Phenyl-imidazoquinolin-4(5H)-one derivatives as selective and orally available mPGES-1 inhibitors

被引:32
作者
Shiro, Tomoya [1 ]
Kakiguchi, Keisuke [2 ]
Takahashi, Hirotada [1 ]
Nagata, Hidetaka [1 ]
Tobe, Masanori [2 ]
机构
[1] Dainippon Sumitomo Pharma Co Ltd, Drug Res Div, Konohana Ku, Osaka 5540022, Japan
[2] Dainippon Sumitomo Pharma Co Ltd, Drug Res Div, Suita, Osaka 5640053, Japan
关键词
mPGES-1; PGE(2); Imidazoquinolin-4(5H)-one; Oral absorption; PROSTAGLANDIN E-2 SYNTHASE; THERAPEUTIC TARGET; BIOLOGICAL EVALUATION; MICE LACKING; PAIN; BIOSYNTHESIS; INFLAMMATION; POTENT; SAR;
D O I
10.1016/j.bmc.2013.03.069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To identify compounds with strong mPGES-1 inhibitory activity and clear in vitro ADME profile, we optimized the lead compound 1 by carrying our substitutions at the C(7)-and C(8)-positions. Replacement of the bromine atom of 1 with various substituents led to identification of the phenyl group as the best C(7)-substituent giving strong inhibitory activity with good in vitro ADME profile. Further SAR examination on both the C(2)-and the C(7)-phenyl groups provided compound 39 as the best candidate for further development. Compound 39 exhibited strong mPGES-1 inhibitory activity (IC50 = 4.1 nM), potent cell-based functional activity (IC50 = 33 nM) with good mPGES-1 selectivity (over 700-fold), excellent in vitro ADME profile, and good oral absorption in rat PK study. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2868 / 2878
页数:11
相关论文
共 23 条
[1]   Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation [J].
Arhancet, Graciela B. ;
Walker, Daniel P. ;
Metz, Sue ;
Fobian, Yvette M. ;
Heasley, Steven E. ;
Carter, Jeffrey S. ;
Springer, John R. ;
Jones, Darin E. ;
Hayes, Michael J. ;
Shaffer, Alexander F. ;
Jerome, Gina M. ;
Baratta, Michael T. ;
Zweifel, Ben ;
Moore, William M. ;
Masferrer, Jaime L. ;
Vazquez, Michael L. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) :1114-1119
[2]  
Avdeef A., 2003, ABSORPTION DRUG DEV
[3]   Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease [J].
Chaudhry, Uzma A. ;
Zhuang, Hean ;
Crain, Barbara J. ;
Dore, Sylvain .
ALZHEIMERS & DEMENTIA, 2008, 4 (01) :6-13
[4]   Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function [J].
Cheng, Y ;
Wang, M ;
Yu, Y ;
Lawson, J ;
Funk, CD ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1391-1399
[5]   Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors [J].
Cote, Bernard ;
Boulet, Louise ;
Brideau, Christine ;
Claveau, David ;
Ethier, Diane ;
Frenette, Richard ;
Gagnon, Marc ;
Giroux, Andre ;
Guay, Jocelyne ;
Guiral, Sebastien ;
Mancini, Joseph ;
Martins, Evelyn ;
Masse, Frederic ;
Methot, Nathalie ;
Riendeau, Denis ;
Rubin, Joel ;
Xu, Daigen ;
Yu, Hongping ;
Ducharme, Yves ;
Friesen, Richard W. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (24) :6816-6820
[6]   In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs [J].
Dressman, JB ;
Reppas, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S73-S80
[7]   Prostaglandins and leukotrienes: Advances in eicosanoid biology [J].
Funk, CD .
SCIENCE, 2001, 294 (5548) :1871-1875
[8]   Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)-oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)-oxy]phenoxy}propionic acid [J].
Hazeldine, ST ;
Polin, L ;
Kushner, J ;
White, K ;
Corbett, TH ;
Biehl, J ;
Horwitz, JP .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) :1069-1081
[9]   Prostaglandin E2 synthase inhibition as a therapeutic target [J].
Iyer, Jitesh P. ;
Srivastava, Punit K. ;
Dev, Rishabh ;
Dastidar, Sunanda G. ;
Ray, Abhijit .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) :849-865
[10]   Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1 [J].
Kamei, D ;
Yamakawa, K ;
Takegoshi, Y ;
Mikami-Nakanishi, M ;
Nakatani, Y ;
Oh-ishi, S ;
Yasui, H ;
Azuma, Y ;
Hirasawa, N ;
Ohuchi, K ;
Kawaguchi, H ;
Ishikawa, Y ;
Ishii, T ;
Uematsu, S ;
Akira, S ;
Murakami, M ;
Kudo, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33684-33695